Poitiers University Hospital
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.chu-poitiers.fr
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment for BRAFV600E-Mutant Metastatic Colorectal Cancer
A phase II clinical trial, FIRE-4.5, compared the efficacy of FOLFOXIRI combined with cetuximab versus bevacizumab as first-line treatment for BRAFV600E-mutant metastatic colorectal cancer, finding bevacizumab-based chemotherapy preferable.
© Copyright 2025. All Rights Reserved by MedPath